You just read:

EMBL Ventures Portfolio Company, ViraTherapeutics Acquired by Boehringer Ingelheim in EUR 210 Million (USD 245 Million) Transaction

News provided by

EMBL Ventures

Sep 13, 2018, 02:00 ET